Monocytes have many faces

December 20, 2017, University of Bonn
Dr. Branko Cirovic, Jil Sander, Prof. Dr. Joachim Schultze and Dr. Andreas Schlitzer at the LIMES-Institute of University of Bonn. Credit: Barbara Frommann/Uni Bonn

When the immune system mobilizes its troops, antigen-presenting cells play an important role. They emerge from white blood cells (monocytes) that circulate in the blood. An international research team under the leadership of the University of Bonn has now taken a closer look at these important helpers. The research revealed that the monocyte-derived cells are not identical descendants, but rather a very diverse mixture. This finding is important for the further development of tailor-made immunotherapies for combating tumor cells. The scientists now present their findings in the renowned journal Immunity.

For more than two decades, monocyte-derived (moDCs) have been obtained from patients' blood for immunotherapy to treat various cancers, for example melanoma, lung or colon cancer. It was assumed that these therapeutically used are identical to dendritic cells. Dendritic cells have become known as the most potent antigen-presenting cells. They recognize foreign structures of invaders, pick them up and present them to other immune cells to strengthen the targeted defense.

Immunotherapy is effective only for a small proportion of patients

"Only a small proportion of patients respond to therapy with moDCs, whilst very little effect is seen in the vast majority of patients," says Dr. Andreas Schlitzer of the University of Bonn. Using the latest high-tech methods, Prof. Dr. Joachim Schultze and Dr. Schlitzer, together with their international colleagues, researched the properties of these special cells.

Using human blood, the scientists extracted monocytes which they transformed into a large variety of and analyzed using state-of-the-art methods. What is the activity of different genes of different moDCs? How is their metabolism? Which messengers and stimulants do they respond to? It became clear that there is a huge variety of moDCs.

"Using state-of-the-art computer-assisted models, we were able to show that moDCs differ from dendritic cells and present a mixture of cells with very diverse properties and functions," explains lead author Jil Sander from the LIMES Institute.

"MoDCs have an extraordinarily large plasticity, enabling them to tailor their response to pathogens, tumors or endogenous danger signals. This ability is fine-tuned by specific gene regulation," adds second lead author Dr. Susanne V. Schmidt from the Institute of Innate Immunity of University Hospital Bonn. They most closely resemble that occur in inflammation.

The wide variety of different moDCs could explain why moDCs activate the immune system against the only in some patients. "Our results are the basis for tailoring moDCs for the patients, thereby significantly improving cancer immunotherapy," says Prof. Schultze from the LIMES Institute.

Time aspect is crucial for cell differentiation

Additionally, the research team achieved important results for basic research. "The time aspect had been largely ignored so far in the differentiation of monocytes," says Dr. Schlitzer. Depending on how long the substance, for example interleukin 4, acted on the cells, the moDCs could be very different. The researchers agree that the potential of monocyte-derived dendritic cells is underestimated.

Explore further: Immune cells derived from specialised progenitors

More information: Jil Sander et al, Cellular Differentiation of Human Monocytes Is Regulated by Time-Dependent Interleukin-4 Signaling and the Transcriptional Regulator NCOR2, Immunity (2017). DOI: 10.1016/j.immuni.2017.11.024

Related Stories

Immune cells derived from specialised progenitors

May 5, 2017
Dendritic cells are gatekeepers of Immunity and are crucial for the detection and initiation of Immunity against pathogens and foreign substances. Up to now dendritic cell subtypes were thought to develop from one common ...

Understanding the origins and function of CD14+ immune cells

February 4, 2015
Dendritic cells and macrophages are immune cells that orchestrate diverse immune functions within many body tissues, including the skin. New work by A*STAR researchers and colleagues shows that CD14+ cells in the skin—long ...

Mechanism identified of impaired dendritic cell function that weakens response to cancer

December 14, 2017
A new study from The Wistar Institute revealed the mechanism implicated in the defective function of tumor-associated dendritic cells (DCs), a specialized type of immune cells that expose the antigens on their surface to ...

Guards of the human immune system unraveled

December 16, 2016
Dendritic cells represent an important component of the immune system: they recognize and engulf invaders, which subsequently triggers a pathogen-specific immune response. Scientists of the University Hospital Erlangen of ...

New types of blood cells discovered

April 21, 2017
Scientists have identified new classes of cells in the human immune system.

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.